Agenda August 02, 2016 Welcome Recognition of Sponsors Update - - PowerPoint PPT Presentation

▶
agenda
SMART_READER_LITE
LIVE PREVIEW

Agenda August 02, 2016 Welcome Recognition of Sponsors Update - - PowerPoint PPT Presentation

Jan 01, 2024 383 likes •740 views

Agenda August 02, 2016 Welcome Recognition of Sponsors Update ACC Biotechnology and Medical Devices Program Nishi Viswanathan, Dell Medical School Health Product Innovation Team Networking Break Patti Rossman

slide-1
SLIDE 1

Agenda

Welcome

  • Recognition of Sponsors
  • Update ACC Biotechnology and Medical Devices Program
  • Nishi Viswanathan, Dell Medical School Health Product

Innovation Team

  • Networking Break
  • Patti Rossman “It’s All About Timing Establishing Your

QMS”

  • Rebecca Jones McKnight J.D. DLA Piper Update On

Current Issues Surrounding The Medical Device Community

  • Med TechTx 2016 Update

Adjourn

August 02, 2016

slide-2
SLIDE 2

August 2, 2016

Thank you to our sponsors

slide-3
SLIDE 3

Biotechnology at ACC Sangeetha Krishnan

slide-4
SLIDE 4

Overview of Biotech Department

  • Works with the local bioscience industry to

educate students in basic laboratory skills, math skills, genetic engineering, protein purification, cell culture, quality assurance and quality control principles, regulations, bioinformatics, computer skills, ethics, documentation, and teamwork

slide-5
SLIDE 5

Overview of Biotech Department

  • Students are educated to work in a variety of

positions that span different kinds of fields including pharmaceutical, molecular diagnostics, manufacturing, research and cancer research, fisheries and wildlife, and cell culture

slide-6
SLIDE 6

Overview of Biotech Dept

  • The Biotechnology Program has a separate preparation room,

and cell culture and storage room at both facilities and a shared lecture and instrumentation room

  • Students are taught on equipment such as real-Time PCR

machines, HPLCs, FPLCs, GCs, laminar flood hoods, fluorescent scopes, bioreactors and fermenters, NanoDrop spectrophotometers, and bioanalyzers

slide-7
SLIDE 7

Current Programs

  • Level One – Certificate in Biotechnology
  • Level Two – Certificate in Biomanufacturing
  • Associates of Applied Science in Biotechnology
  • Advanced Technical Certificate in Biotechnology
slide-8
SLIDE 8

Level One Certificate in Biotechnology

  • Entry level
  • Provides students basic laboratory training in a

regulated environment

  • Prepares students to function as entry level lab

technicians in biosciences labs

  • 18 credit hours
slide-9
SLIDE 9

Level Two Certificate in Biomanufacturing

  • Entry level
  • Provides students the basic skills for a

biomanufacturing job

  • Enter the workforce quickly
  • 44 credit hours
slide-10
SLIDE 10

Associates of Applied Science (AAS) in Biotechnology

  • Comprehensive two-year program
  • Includes general academics and specialized biotech training

for working in biosciences laboratories

  • Provides students with more advanced knowledge in cell

culture, instrumentation, and molecular techniques such as qPCR

  • Internship in industry required
  • 60 credit hours
slide-11
SLIDE 11

Advanced Technical Certificate in Biotechnology

  • Designed for graduate-level students who already

hold a bachelor’s or associate’s degree

  • For students who are interested in updating their

skills or transitioning into a biotech career

  • Advanced hands-on training
  • 30 credit hours
slide-12
SLIDE 12

New Biomedical Devices Program

  • Will commence in 2017
  • Innovative, first of its kind, hands on program designed with

input from area employers

  • Enables students to gain mid-level technical skills appropriate

for Biomedical Device careers

  • Intended to meet the needs of continued growth of expanding

numbers of biomedical companies in the Central Texas area

  • Offers a one-year Certificate, a Level Two Certificate, and an

AAS degree in Biomedical Devices

slide-13
SLIDE 13

New Biomedical Devices Program

  • Courses include:
  • Introduction to Medical Devices
  • Introduction to 3-D Fabrication
  • Instrumentation and Data Analysis
  • Establish a Biomedical device laboratory with

industry appropriate state-of-the-art equipment

slide-14
SLIDE 14

Texas Health Catalyst & Health Product Innovation @ Dell Medical School

TMDA meeting August 2nd, 2016

Nishi Viswanathan, MBBS, MBA Associate Director, Translational Research & Innovation Dell Medical School

slide-15
SLIDE 15

Health Product Innovation Team

Ruben Rathnasingham, PhD

  • Asst. Dean, Health Product Innovation

rubenr@austin.utexas.edu Nishi Viswanathan, MBBS, MBA Associate Director, Translational Research & Innovation nishi.viswanathan@austin.utexas.edu Robin Richardson Project Manager, Health Product Innovation robin.richardson@austin.utexas.edu

slide-16
SLIDE 16

Health Innovation Product Goals

  • Identify promising ideas and support their translation toward clinically and

commercially viable solutions that improve health outcomes

  • Create a pipeline of healthcare innovation at UT that commercialization

partners are eager to take to market.

  • Strategy

– solve unmet needs, as opposed to supporting technologies – invite industry to participate in defining the target profiles of clinically and commercially viable solutions that solve these unmet needs – create an ecosystem to maximize success

  • First initiative: Texas Health Catalyst
slide-17
SLIDE 17

Texas Health Catalyst Awards Process

slide-18
SLIDE 18

Texas Health Catalyst Awards Process

slide-19
SLIDE 19

Texas Health Catalyst Awards Process

slide-20
SLIDE 20

Partners

#TXHealthCatalyst

Eligibility

UT Austin faculty Seton Healthcare clinicians Dell Medical School clinical affiliates What about companies?

slide-21
SLIDE 21

Texas Health Catalyst Advisors

Leveraging Central Texas healthcare ecosystem to:

  • Evaluate UT inventions
  • Identify out-licensing opportunities
  • Provide reality check on out-licensing terms and potential for success

> 100 volunteer members with diverse expertise

  • Industry
  • Academia
  • Clinicians
  • Venture Capital
  • IP/Clinical/Regulatory
slide-22
SLIDE 22

Multidisciplinary Advisors

Luminex Corporation Pfizer Johnson & Johnson Texo Ventures UT Austin & Dell Med Popper & Co. GlaxoSmithKline PTV Healthcare Capital Vermillion Drug Dynamics Institute Integra Austin Technology Incubator Sante Ventures Genentech Seton Healthcare System True Wealth Innovations Cognitive Scale TechStars Medical Innovation Labs BioMarin Superior Health Plan Center for Health Communication Mirna Therapeutics DreamIt Ventures Aeglea Biotherapeutics Live Oak Ventures United Healthcare Mystic Pharmaceuticals TVA Medical Ottobock Spindletop Capital Capital Factory McCombs Business School ARM Endomag Asuragen

slide-23
SLIDE 23

College of Natural Sciences − Richard Crooks, PhD − James W. Tunnell, PhD Cockrell School of Engineering − Jason Reichenberg, MD Dell Medical School & Seton Healthcare Family College of Natural Sciences − Stephen Martin, PhD − James Sahn, PhD

#TXHealthCatalyst

Treatment for Neurodegenerative Disorders Intraoperative Assessment for Surgical Removal of Skin Cancers Heart-Health Monitoring Sensor

Selected 2015-16 Awardees

slide-24
SLIDE 24

#TXHealthCatalyst

slide-25
SLIDE 25

Texas Health Catalyst 2.0: How can we maximize the likelihood of success?

Key Implementation Steps

  • Begin with health priorities
  • Identify gaps
  • Articulate problem statements
  • Invite multidisciplinary

innovators to develop solutions

  • Enable clinical validation
slide-26
SLIDE 26

2016-17 Clinical Focus Areas

Women’s Health

Examples of problem statements:

  • Measuring post-partum blood loss
  • Improving care before, during and after

pregnancy

  • Better contraceptive methods (e.g.

IUDs)

  • Cancer diagnosis and treatment

Musculoskeletal Conditions

Examples of problem statements:

  • Improve effectiveness of rehab
  • Lower readmissions & revisions
  • Implant positioning/monitoring

tools (not “better implants”)

  • Appropriate patient selection
  • Cost-effective implants

Future focus areas: Neurology, Oncology, Psychiatry/Mental Health, Pediatrics…….

slide-27
SLIDE 27
  • Scientific rationale
  • Clinical unmet need
  • Commercial attractiveness
  • Development feasibility
  • Intellectual property potential
  • New: Ability to improve value of care

#TXHealthCatalyst

2016-17 Proposal Review Criteria

slide-28
SLIDE 28

Texas Health Catalyst Process Identify Support Enable

Call for applications/review

  • Specific problem

statements

  • Expert panel reviews
  • Select most promising

projects based on specific criteria Customized support

  • Mentor and iterate
  • Demo day
  • Funding (up to $100,000)

Metrics

  • R&D milestones
  • Intellectual property
  • Customers/partnerships
  • Follow-on funding
  • Clinical validation
  • Academic exit through

licensing or startup creation 5 mths 1 – 3 yrs

slide-29
SLIDE 29

Long Term View

Texas Health Catalyst Iterate/ Validate

Pilot Co- Innovate Partner Incubate Invest Procure

#TXHealthCatalyst

slide-30
SLIDE 30

It's All About Timing - Establishing Your QMS

Patti Rossman, President, Globiox

slide-31
SLIDE 31

Rebecca Jones McKnight

Industry Update From DLA Piper

slide-32
SLIDE 32
slide-33
SLIDE 33

Panels of Key Stakeholder Groups

Clinical Leaders: “Begin With the End in Mind” Value Examiners: Focus on the “Triple Aim” C-Suite: “How Much Should They Matter to You?” Industry Leaders: “Predicting the Future” Entrepreneur Reality Check: “Lessons from the Front Lines”

slide-34
SLIDE 34

Register Today!

www.Medtechtx.org

slide-35
SLIDE 35

Check out the NEW TMDA website at: www.texmda.org Follow Us on LinkedIn, Facebook and Twitter

Email tridenhour@texmda.org if you wish to be listed as a participant or if you are interested in becoming a sponsor.